They had everything to do with the spin-off. They owned the company and spun it off.
In the past, our shareholders benefited when we spun off ATC Technology, Inc., (TRUE) one of our subsidiaries (TRUE), into a separate publicly traded company (TRUE), which has now become Cellular Biomedicine Group, Inc. (http://www.cellbiomedgroup.com/) (TRUE) and is trading on the Nasdaq Stock Market (TRUE).
Now PHIL may not have had anything to do with the business of ATC/EastBridge/CBMG but that doesn't matter. What matters is they issued the dividends to shareholders and spun the company off and the shares they distributed became valuable if they were held onto because the company went to the NASDAQ.
All of what they have stated is true and factual.
They still had nothing to do with the spin off becoming a nasdaq company but they are issuing a PR like they had something do with it.
They did have something to do with it - they spun the company off. If they hadn't spun the company off it would not have gone to the NASDAQ and shareholders would have never received shares of what is now a NASDAQ company.